Succinylated human serum albuminAlternative Names: Suc-HSA
Latest Information Update: 24 Oct 2006
At a glance
- Originator Sanquin Blood Supply Foundation; University of Groningen
- Class Antivirals
- Mechanism of Action HIV fusion inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II HIV-1 infections